Hebert, A. A., Guide, S. V., Groysman, V., Gonzalez, M. E., Blanco, D., Laquer, V., . . . Higham, R. C. (2025). Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2–11 Years. Wiley. https://doi.org/10.1111/pde.70013
Chicago-Zitierstil (17. Ausg.)Hebert, Adelaide A., et al. Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis In Children Aged 2–11 Years. Wiley, 2025. https://doi.org/10.1111/pde.70013.
MLA-Zitierstil (9. Ausg.)Hebert, Adelaide A., et al. Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis In Children Aged 2–11 Years. Wiley, 2025. https://doi.org/10.1111/pde.70013.